Is it Possible to Predict The Market Access of a New Pharmaceutical in Germany? A Systematic Evaluation of Federal Joint Committee Decisions on Early Benefit Assessments According to The German Law For Reforming The Market of Pharmaceuticals

Saved in:
Bibliographic Details
Published inValue in health Vol. 17; no. 7; p. A437
Main Authors Schwander, B, Banz, K, Kaier, K, Walzer, S
Format Journal Article
LanguageEnglish
Published United States 01.11.2014
Subjects
Internal Medicine
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2014.08.1135